Description:

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0226) NCT00075764 S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3223C5F-32FD-268C-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3223C5F-32FD-268C-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 5/22/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0226) NCT00075764

Details

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0226)
    1. No Instruction available.
SWOG clinical trial data
Target Lesions
Assessment Type
12 more items in the detailed view.
Non-target Disease
Assessment Type
12 more items in the detailed view.
Extent
New Lesions
Assessment Type
12 more items in the detailed view.
Symptomatic deterioration
Comments
Ccrr Module For Southwest Oncology Group Follow-up Tumor Assessment Form (s0226)
Back to the top of the page